[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2014MN02599A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02599A
IN2014MN02599A IN2599MUN2014A IN2014MN02599A IN 2014MN02599 A IN2014MN02599 A IN 2014MN02599A IN 2599MUN2014 A IN2599MUN2014 A IN 2599MUN2014A IN 2014MN02599 A IN2014MN02599 A IN 2014MN02599A
Authority
IN
India
Prior art keywords
spinosad
formulation
provides
infestation
cat
Prior art date
Application number
Inventor
Daniel Earl Snyder
Michelle Leigh Totten
Kari Lynette Riggs
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IN2014MN02599A publication Critical patent/IN2014MN02599A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ABSTRACT This invention provides a single dose oral formulation of spinosad for the extended control of a C. infestation on a cat at a predictable dose of spinosad that is suitable for administration once every 30 days (. one month). The invention also provides methods of using the formulation of spinosad.
IN2599MUN2014 2012-07-26 2013-07-18 IN2014MN02599A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261676023P 2012-07-26 2012-07-26
PCT/US2013/050987 WO2014018352A1 (en) 2012-07-26 2013-07-18 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

Publications (1)

Publication Number Publication Date
IN2014MN02599A true IN2014MN02599A (en) 2015-07-24

Family

ID=48877579

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2599MUN2014 IN2014MN02599A (en) 2012-07-26 2013-07-18

Country Status (14)

Country Link
US (2) US9220719B2 (en)
EP (1) EP2877005A1 (en)
JP (1) JP2015523388A (en)
KR (1) KR20150023831A (en)
CN (1) CN104703474A (en)
AR (1) AR091769A1 (en)
AU (1) AU2013293350B2 (en)
BR (1) BR112015001152A2 (en)
CA (1) CA2878009A1 (en)
EA (1) EA201590097A1 (en)
IN (1) IN2014MN02599A (en)
MX (1) MX2015001137A (en)
TW (1) TW201416077A (en)
WO (1) WO2014018352A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183512A1 (en) * 2017-03-28 2018-10-04 Piedmont Animal Health, Llc Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
JP2024526193A (en) * 2021-06-25 2024-07-17 イン ザ ボウル アニマル ヘルス，インコーポレーテッド Oral feline feed and method for controlling flea infestations in felines - Patents.com

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1207756B1 (en) * 1999-08-12 2006-04-26 Eli Lilly And Company Use of spinosad or a formulation comprising spinosad
WO2002077005A1 (en) * 2001-03-21 2002-10-03 Dow Agroscoences Llc Pesticidal spinosyn derivatives
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US20070149464A1 (en) * 2005-06-15 2007-06-28 Pfizer Inc. Combination
EP2248422A1 (en) 2009-05-08 2010-11-10 Novartis AG Ectoparasiticidal compositions
US20120003661A1 (en) 2010-07-05 2012-01-05 C3 Jian, Inc. Methods and devices for the selective detection of microorganisms
AU2011323082B2 (en) * 2010-11-05 2015-06-11 Eli Lilly And Company Methods for inhibiting insect infestations

Also Published As

Publication number Publication date
EA201590097A1 (en) 2015-06-30
TW201416077A (en) 2014-05-01
MX2015001137A (en) 2015-10-14
WO2014018352A1 (en) 2014-01-30
KR20150023831A (en) 2015-03-05
EP2877005A1 (en) 2015-06-03
BR112015001152A2 (en) 2017-06-27
JP2015523388A (en) 2015-08-13
US20160101127A1 (en) 2016-04-14
AR091769A1 (en) 2015-02-25
CN104703474A (en) 2015-06-10
US20140031306A1 (en) 2014-01-30
US9220719B2 (en) 2015-12-29
AU2013293350B2 (en) 2015-07-23
AU2013293350A1 (en) 2015-02-05
CA2878009A1 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
HK1247822A1 (en) Formulations for oral administration of active agents
EP3302426A4 (en) D2o stabilized pharmaceutical formulations
EP4269440A3 (en) Composition for treating il-6-related diseases
PH12016501883B1 (en) Insecticidal and nematocidal active ingredient combinations
SG10201810879VA (en) Pharmaceutical compounds
IL275639A (en) Formulation for administration of rna
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
HUP1700253A1 (en) Solid preparations for oral administration
MX2017003476A (en) Cytotoxic and anti-mitotic compounds, and methods of using the same.
NZ730475A (en) Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)
EP3500291A4 (en) Formulations for oral administration of active agents
EP3213746A4 (en) Pharmaceutical composition for oral administration comprising taxane
MX2018005358A (en) Optimised high-dose mesalazine-containing tablet.
EP3318259A4 (en) Stable pharmaceutical composition for oral administration
EP3682016A4 (en) Formulations for compound delivery
IN2014MN02599A (en)
MX2016005348A (en) Novel compounds.
NZ712341A (en) A crystalline form of an anxiolytic compound
PH12016501733A1 (en) Pharmaceutical composition for preventing or treating skin rash
EP3302430A4 (en) Liquid formulations of celecoxib for oral administration
EP3326628A4 (en) Pharmaceutical composition for oral administration comprising high concentration taxane